<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">31529</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Subclinical interstitial lung disease associated with rheumatoid arthritis</article-title><trans-title-group xml:lang="ru"><trans-title>Субклинический вариант течения интерстициального заболевания легких, ассоциированного с ревматоидным артритом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bestaev</surname><given-names>D V</given-names></name><name xml:lang="ru"><surname>Бестаев</surname><given-names>Д В</given-names></name></name-alternatives><email>davidbestaev@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ФГБУ "НИИ ревматологии им. В.А. Насоновой" РАМН, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-05-15" publication-format="electronic"><day>15</day><month>05</month><year>2014</year></pub-date><volume>86</volume><issue>5</issue><issue-title xml:lang="en">VOL 86, NO5 ()</issue-title><issue-title xml:lang="ru">ТОМ 86, №5 (2014)</issue-title><fpage>106</fpage><lpage>108</lpage><history><date date-type="received" iso-8601-date="2020-04-10"><day>10</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/31529">https://ter-arkhiv.ru/0040-3660/article/view/31529</self-uri><abstract xml:lang="en"><p>Interstitial lung disease (ILD) in rheumatoid arthritis (RA) is its extra-articular manifestation. At the same time, ILD considerably worsens the prognosis of the disease. Mortality rates for interstitial pulmonary fibrosis are 6% of all-cause mortality in RA patients. ILD can be identified by clinical examination only in 2-6% of cases, by plain chest X-ray in 1-6%, and by high-resolution computed tomography in 50-60%. The paper deals with subclinical ILD and discusses the state-of-the-art of investigations in this area.</p></abstract><trans-abstract xml:lang="ru"><p>Аннотация. Интерстициальное заболевание легких (ИЗЛ) при ревматоидном артрите (РА) является его внесуставным проявлением. При этом ИЗЛ значительно ухудшает прогноз заболевания. Смертность, обусловленная интерстициальным легочным фиброзом, составляет 6% всех причин смерти больных РА. При клиническом исследовании ИЗЛ удается распознать только в 2-6% случаев, при обзорной рентгенографии органов грудной клетки - у 1-6% больных, а при использовании компьютерной томографии высокого разрешения - у 50-60%. Работа посвящена субклиническому варианту ИЗЛ. Обсуждается современное состояние исследований в данной области.</p></trans-abstract><kwd-group xml:lang="en"><kwd>rheumatoid arthritis</kwd><kwd>subclinical course</kwd><kwd>interstitial lung disease</kwd><kwd>high-resolution computed tomography</kwd><kwd>external respiratory function</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ревматоидный артрит</kwd><kwd>субклиническое течение</kwd><kwd>интерстициальное заболевание легких</kwd><kwd>компьютерная томография высокого разрешения</kwd><kwd>функция внешнего дыхания</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Насонова В.А., Насонов Е.Л. Рациональная фармакотерапия ревматических заболеваний: Руководство для практикующих врачей. М: Литтерра 2003; 86.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kim E.J., Elicker B.M., Maldonado F. et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010; 35 (6): 1322-1328.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Kim E.J., Collard H.R., King T.E. Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009; 136 (5): 1397-1405.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ascherman D.P. Interstitial lung disease in rheumatoid arthritis. Curr Rheumatol Reports 2010; 12 (5): 363-369.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bongartz T., Nannini C., Medina-Velasquez Y.F. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis - a population-based study. Arthritis Rheum 2010; 62 (6): 1583-1591.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Sawada T., Inokuma S., Sato T. et al. Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis. Rheumatology 2009; 48 (9): 1069-1072.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Picchianti Diamanti A., Germano V., Bizzi E. et al. Interstitial lung disease in rheumatoid arthritis in the era of biologics. Pulmon Med 2011; 2011: 931342.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gochuico B.R., Avila N.A., Chow C.K. et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008; 168 (2): 159-166.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Juan Chen, Yong Hong Shi, XiaoPing Wang et al. Asymptomatic Preclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease. Clin Dev Immunol 2013; 2013: 406927.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Arnett F.C., Edworthy S.M., Bloch D.A. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31 (3): 315-324.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>ATS/ERS task force. Standardization of spirometry: standardization of lung function testing, 2005 upd. Eur Resp J 2005; 26: 319-338.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Насонов Е.Л., Каратаев Д.Е., Балабанова Р.М. Ревматоидный артрит. В кн.: Насонова В.А., Насонов Е.Л. Ревматология. Национальное руководство. М: ГЭОТАР-Медиа 2008: 290-331.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Liote H. Pulmonary manifestation of rheumatoid arthritis. Revue des Maladies Respiratoires 2008; 25 (8): 973-988.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Biederer J., Schnabel A., Muhle C. et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 2004; 14 (2): 272-280.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Hamblin M.J., Horton M.R. Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulmon Med 2011; 2011: ID 872120.</mixed-citation></ref></ref-list></back></article>
